Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children between 2 and 17 years old
- Children who have been diagnosed with Cystic Fibrosis
- Children who are currently being treated with the medication combination Elexacaftor/Tezacaftor/Ivacaftor (sold under the brand names Trikafta® or Kaftrio®)
Who may not be able to join:
- Children who have had an allergic reaction to earlier Cystic Fibrosis medications, specifically Ivacaftor or lumacaftor
- People who are pregnant
- Children who are already taking part in another clinical study that involves a type of drug known as a CYP3A4 inhibitor (confirm with trial site)
- Children who have received a lung transplant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 4 72 07 19 28
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Trough Concentration [Cmin] of Elexacaftor, Ivacaftor and Tezacaftor; Maximum Plasma Concentration [Cmax]; Area Under the Concentration Time Curve between two administrations of Elexacaftor, Ivacaftor and Tezacaftor
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.